The Clorox Company (NYSE:CLX) Position Increased by Sowell Financial Services LLC

Sowell Financial Services LLC raised its position in The Clorox Company (NYSE:CLX) by 2.2% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 21,551 shares of the company’s stock after purchasing an additional 473 shares during the quarter. Sowell Financial Services LLC’s holdings in Clorox were worth $3,173,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the company. Norges Bank acquired a new stake in shares of Clorox during the 4th quarter valued at about $259,041,000. FMR LLC lifted its stake in Clorox by 75.4% in the fourth quarter. FMR LLC now owns 1,361,758 shares of the company’s stock valued at $221,163,000 after acquiring an additional 585,526 shares during the last quarter. Marshall Wace LLP grew its position in Clorox by 549.8% in the fourth quarter. Marshall Wace LLP now owns 542,726 shares of the company’s stock worth $88,144,000 after acquiring an additional 459,203 shares in the last quarter. ExodusPoint Capital Management LP grew its position in Clorox by 187.9% in the fourth quarter. ExodusPoint Capital Management LP now owns 698,900 shares of the company’s stock worth $113,508,000 after acquiring an additional 456,114 shares in the last quarter. Finally, Man Group plc increased its stake in shares of Clorox by 154.6% during the 4th quarter. Man Group plc now owns 570,503 shares of the company’s stock worth $92,655,000 after purchasing an additional 346,449 shares during the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Trading Up 0.6%

Shares of Clorox stock opened at $123.82 on Tuesday. The Clorox Company has a 52-week low of $122.84 and a 52-week high of $171.37. The firm has a market capitalization of $15.26 billion, a PE ratio of 33.83, a price-to-earnings-growth ratio of 2.62 and a beta of 0.54. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The company’s fifty day moving average price is $134.66 and its two-hundred day moving average price is $147.91.

Clorox (NYSE:CLX) last posted its earnings results on Monday, May 5th. The company reported $1.45 earnings per share for the quarter, missing analysts’ consensus estimates of $1.57 by ($0.12). Clorox had a net margin of 6.38% and a return on equity of 316.87%. The business had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.74 billion. During the same period in the previous year, the firm earned $1.71 EPS. The business’s revenue was down 8.0% compared to the same quarter last year. On average, analysts expect that The Clorox Company will post 7.15 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on CLX shares. Barclays reduced their price objective on shares of Clorox from $134.00 to $129.00 and set an “underweight” rating for the company in a research note on Wednesday, May 7th. Morgan Stanley reduced their price target on Clorox from $165.00 to $150.00 and set an “equal weight” rating for the company in a research report on Tuesday, May 6th. Evercore ISI set a $140.00 price target on Clorox and gave the stock an “underperform” rating in a research note on Tuesday, May 6th. Citigroup cut their price objective on Clorox from $165.00 to $150.00 and set a “neutral” rating on the stock in a research note on Monday, April 14th. Finally, UBS Group reduced their target price on Clorox from $176.00 to $154.00 and set a “neutral” rating for the company in a report on Thursday, April 17th. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $151.23.

Insider Transactions at Clorox

In other Clorox news, Director Pierre R. Breber purchased 4,000 shares of the business’s stock in a transaction that occurred on Wednesday, May 7th. The stock was acquired at an average cost of $136.57 per share, with a total value of $546,280.00. Following the completion of the acquisition, the director now directly owns 4,000 shares of the company’s stock, valued at $546,280. This represents a ∞ increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.57% of the stock is owned by insiders.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.